112 related articles for article (PubMed ID: 8337137)
1. Therapeutic value of interleukin-3 given alone or in combination with other cytokines.
Ganser A; Hoelzer D
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):245-6. PubMed ID: 8337137
[No Abstract] [Full Text] [Related]
2. [Clinical use of hematopoietic growth factors].
Robak T
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
[No Abstract] [Full Text] [Related]
3. Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications.
Ganser A; Ottmann OG; Hoelzer D
Stem Cells; 1993 Nov; 11(6):465-73. PubMed ID: 8111306
[No Abstract] [Full Text] [Related]
4. An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach.
Mundle S; Lefebvre P; Vekeman F; Duh MS; Rastogi R; Moyo V
Cancer; 2009 Feb; 115(4):706-15. PubMed ID: 19152429
[TBL] [Abstract][Full Text] [Related]
5. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R
Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076
[TBL] [Abstract][Full Text] [Related]
6. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
7. The use of growth factors in severe aplastic anaemia (SAA).
Hinterberger W; Hoffmann S; Bettelheim P; Geissler K; Maurer D; Muhm M
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():129-30. PubMed ID: 2697425
[No Abstract] [Full Text] [Related]
8. [Clinical use of hematopoietic growth factors].
Krusius T
Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
[No Abstract] [Full Text] [Related]
9. Severe idiopathic congenital aplastic anemia: role of hematopoietic growth factors.
Vermylen C; Cornu G; DeWitte M; Heremans MT; Ninane J; Brichard B
Bone Marrow Transplant; 1993 Oct; 12(4):413-5. PubMed ID: 8275043
[TBL] [Abstract][Full Text] [Related]
10. [Clinical application of new cytokines].
Kitamura K
Rinsho Byori; 1993 Apr; 41(4):390-8. PubMed ID: 8350499
[TBL] [Abstract][Full Text] [Related]
11. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser A; Hoelzer D
Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
[No Abstract] [Full Text] [Related]
12. Haematopoietic growth factors in the treatment of myelodysplastic syndromes.
Cazzola M
Forum (Genova); 1999; 9(1):49-57. PubMed ID: 10101210
[TBL] [Abstract][Full Text] [Related]
13. [Increase of neopterin after treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF)].
Melichar B; Solichova D; Jebavy L
Presse Med; 1994 Mar; 23(12):581. PubMed ID: 8066063
[No Abstract] [Full Text] [Related]
14. Clinical trials of granulocyte-macrophage colony-stimulating factor for the treatment of aplastic anemia.
Vadhan-Raj S
Immunol Ser; 1992; 57():661-70. PubMed ID: 1504150
[No Abstract] [Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor.
Devereux S; Linch DC
Biotherapy; 1990; 2(4):305-13. PubMed ID: 2148492
[No Abstract] [Full Text] [Related]
16. Clinical use of growth factors in the myelodysplastic syndromes.
Stein RS
Am J Med Sci; 1994 May; 307(5):360-7. PubMed ID: 7513498
[No Abstract] [Full Text] [Related]
17. Use of granulocyte colony-stimulating factor for treatment of aplastic anemia.
Kojima S
Nagoya J Med Sci; 1999 Nov; 62(3-4):77-82. PubMed ID: 10689869
[TBL] [Abstract][Full Text] [Related]
18. Effect of interleukin-3 on responsiveness to granulocyte-colony-stimulating factor in severe aplastic anemia.
Geissler K; Forstinger C; Kalhs P; Knöbl P; Kier P; Kyrle P; Lechner K
Ann Intern Med; 1992 Aug; 117(3):223-5. PubMed ID: 1377461
[No Abstract] [Full Text] [Related]
19. Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
Kasper C; Zahner J; Sayer HG
J Cancer Res Clin Oncol; 2002 Sep; 128(9):497-502. PubMed ID: 12242514
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-mobilized peripheral blood progenitor cells.
Nemunaitis J
Semin Oncol; 1996 Apr; 23(2 Suppl 4):9-14. PubMed ID: 8600547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
